Skip to main content

Procyon Corp

PCYN
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000812306

No open-market purchases or sales by Procyon Corp insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding PCYN, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding PCYN at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Procyon Corp insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 27, 2024 (view filing)4:43 PM ETJun 25-262 daysSpeer Foundation10% OwnerSSale−80.0K$0.1869−$14.9K−5.5%1.38M after2 lots
Apr 1, 2022 (view filing)4:41 PM ETMar 311 daySpeer Foundation10% OwnerSSale−40.0K$0.3786−$15.1K−2.7%1.46M after
Feb 8, 2022 (view filing)5:08 PM ETFeb 71 daySpeer Foundation10% OwnerSSale−15.0K$0.3509−$5.26K−1.0%1.50M after
Dec 7, 2021 (view filing)2:05 PM ETDec 61 daySpeer Foundation10% OwnerSSale−25.0K$0.3232−$8.08K−1.6%1.51M after

Top 10 13F holders, Q2 2026

The largest institutional positions in Procyon Corp at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding PCYN in 13F filings for Q2 2026.